While the WHO study saw reports of suicidal thoughts were slightly higher for semaglutide in particular, the warning applies ...

Patients taking these medicines should tell their health professional if they experience new or worsening depression, ...

Australia’s drug regulator, the Therapeutic Goods Administration (TGA), has added two new safety warnings about mental health ...

The Australian Therapeutic Goods Administration (TGA) has updated and aligned safety warnings for people using GLP-1 and dual ...

FDA and WHO identified semaglutide suicidal thought reports, exceeding those of other diabetes medications in their adverse ...

Australia’s medicines regulator has issued a safety warning over the risk of suicidal thoughts and behaviour linked to drugs ...

The rise of GLP-1 drugs such as Ozempic and Mounjaro has been nothing short of meteoric. Originally developed to treat ...

Australia’s drug regulator, Therapeutic Goods Administration, has issued a new safety warning for Ozempic and similar ...

Ozempic-style medications have been recommended as long-term treatments for obesity under new guidelines released by the ...

Australia's Therapeutic Goods Administration has issued new safety warnings about mental health risks and contraception ...

Australia's GLP-1 boom is accelerating trends reshaping Australia's food landscape, according to a new research.

Analysis has found a link between semaglutide use and suicidal thoughts but not all evidence supports these findings ...